RxDoctor Payments Data

Steven Glass

Psychiatry · Clementon, NJNPI 1659599918

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $300 of the $483 with a category attached, or 62.2%. AbbVie accounts for 62.2% of it on its own, with 2 other manufacturers making up the rest.

$483in general payments, 2019–2025

Across 3 payments — averaging $160.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$300
  • Takeda Pharmaceuticals U.S.A., Inc.$99
  • Alkermes, Inc.$83
$3,866,982in research payments, 2019–2025

Across 176 payments — averaging $21,971 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2.8M
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$405K
  • Boehringer Ingelheim$349K
  • Biohaven Pharmaceuticals, Inc.$277K
  • Supernus Pharmaceuticals, Inc.$13K
  • Hoffmann-la Roche Limited$11K
  • plus $39K from 7 others

What the payments were for

  • Speaking & faculty fees$30062%
  • Food & beverage$18338%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$483 in reported general payments places this provider in the 60th percentile of 1,119 psychiatry providers in New Jersey.

See all psychiatry providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
Alprazolam37$333
Tramadol Hcl11$104
Ibuprofen14$67
Omeprazole11$30
Citalopram HbrCitalopram Hydrobromide13$22

Paid to pharmacies, not to this prescriber.

Other psychiatry in Clementon

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →